Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
SCH-503034
and 10 mg/kg) is subjected to electrolytic injury of the coronary artery
Chemical Name: N-(4-((5-(3-(furan-2-ylmethyl)-4-oxo-1
E-7449 traps PARP1 onto damaged DNA
Formula: C20H22ClNO4
GSK-2606414 - CAS# 1337531-36-8 0435 SCH-503034GSK 2606414, CAS No. 1337531 36 8, is an orally available, potent, and selective PERK inhibitor. GSK 2606414 inhibits PERK activation in cells and inhibits the growth of a human tumor xenograft in mice. Protein kinase R (PKR) like endoplasmic reticulum kinase (PERK) is activated in response to a variety of endoplasmic reticulum stresses implicated in numerous disease states. Evidence that PERK is implicated in tumorigenesis and cancer cell survival
US$ 22.00
US$ 13.00
US$ 38.00
US$ 45.00
US$ 60.00
US$ 17.00
US$ 158.00
US$ 90.00
US$ 70.00
US$ 21.00